tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

AngioDynamics announces first patient enrolled in RECOVER-AV clinical trial

AngioDynamics (ANGO) announced the first patient has been enrolled in the RECOVER-AV clinical trial, a prospective, multi-center, multi-national, single-arm study evaluating the AlphaVac Multipurpose Mechanical Aspiration F1885 System in the treatment of acute, intermediate-risk pulmonary embolism.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1